Objectives: Severe tuberculosis (TB) requiring intensive care unit (ICU)-care is rare but commonly known to be of markedly bad prognosis. Our study aimed to describe this condition and to determine the mortality rate and risk factors associated to mortality.
Introduction
Tuberculosis (TB) is currently the most frequent cause of death due to an infection worldwide (1) . Since the initiation of intensive care units (ICU) in the 60s many potentially life threatening complications and critical illnesses could be efficiently treated. In this respect, the acute respiratory failure due to pulmonary infections is a common reason for admittance to the ICU. However, despite of their high mortality rate, the TB-related critical conditions are rarely reported. The cases of TB requiring intensive care represent 1-3% of all patients with TB (2, 3, 4) . The hospital mortality has been reported to be approximately 60% for patients with respiratory failure due to pulmonary TB. By contrast, the mortality for patients with respiratory failure due to severe pneumonia is only about 25% (5).
The most common reasons for ICU admissions of patients with TB is the development of an acute respiratory distress syndrome (ARDS) (6, 7) and the severe organ failure, such as renal failure (8, 9) . Several studies reported also a critical course in patients with miliary TB and in HIV infected patients with TB (10, 11, 12, 13, 14, 15, 16) , but patient numbers were, especially when reported from Europe, relatively small.
In the present study we aimed to describe the characteristics of TB patients requiring ICU care and to determine the in hospital mortality rate and the predictive factors for mortality.
Patients and methods
Adults patients (>18 yrs) with TB that were admitted to the ICU of Chest Hospital Heckeshorn, Germany between January 1990 and December 2001 were identified retrospectively. The diagnosis of TB was based on the following: 1) positive cultures of sputum, bronchial aspirates or bronchioalveolar lavage fluid (BAL); and/or 2) positive acidfast bacilli smears; and/or 3) clinical and radiological findings.
The following data were obtained from the medical records: demographic characteristics (age, gender, origin), comorbidities, reasons for ICU-admission, health status including Acute Physiology and Chronic Health Evaluation Score II (APACHE) and body mass index (BMI), symptoms, radiological appearance, bacteriological investigation (including results of susceptibility tests), laboratory investigations (total blood cell count, liver and renal function parameters, C-reactive protein, CD4 T-lymphocyte count), blood gas analysis, HIV status, anti-TB treatment, need and duration of mechanical ventilation, ICU-complications (ventilator-associated pneumonia, ARDS, sepsis, tracheostomy), length of hospital/ICU stay, mortality.
A BMI below 20 kg/m 2 was defined as underweight. Chest radiographic patterns were classified according to National TB and Respiratory Disease Association (NTRDA) (17) analyzed and ranked using a multivariate discriminate analysis. All statistical analysis were performed using the computerized Statistical Package of Social Science, Version 11.0.
Results

Patient characteristics
A total of 58 patients with confirmed TB, which was 3% of all TB-patients admitted to the hospital, were admitted to ICU within the study period,. Of them, 15 (25.8%) died during ICU/hospital stay. The baseline characteristics of both survivors and deceased patients are shown in Table 1 .
Disease presentation
The most common symptoms (52/58, 89.6%) were fever, night sweat and consumption with a mean duration from symptom onset to hospital admission of 4 weeks (range 1-26 weeks).
Most of the patients (52/58, 89.6%) presented dyspnea, productive cough and/or hemoptysis.
The duration of these symptoms from onset to admission differed from < 1 week (10 patients), 1-4 weeks (30 patients), to > 4 weeks (10 patients) ( Table 2) .
Acute respiratory failure due to TB was the primary cause for ICU admission in 47/58 (81.1%) patients. Other reasons were exacerbated COPD (n=2), acute gastrointestinal bleeding (n=2), heart failure (n=2). One patient with HIV infection suffered severe respiratory insufficiency due to Pneumocystis jerovecci pneumonia. Other causes were diabetic coma, low levels of potassium, weaning problems after diagnostic thoracotomy, respiratory insufficiency after bronchoscopy, severe anemia, delirium due to alcohol withdrawal and severe cachexia.
At ICU admission or before 46/58 (79.3%) patients with positive TB cultures during the course of the study were initially smear positive in sputum, bronchial aspirates or BAL. In all patients, the TB involved the lung parenchyma. Additional pleural involvement was present in All patients were treated immediately after diagnosis and initially according to the guidelines of the American Thoracic Society and the German Respiratory Society (22) ( Table 2) .
Treatment modifications were due to side effects of the anti-TB treatment: hepatotoxicity (n=35), exanthema (n=7) and ototoxicity (n=14). A withdrawal of ethambutol was necessary in one case due to neuritis of nervus optici.
Corticosteroids were given in 40/58 (68.9%) patients for ARDS (n= 7), severe COPD (n=2) and severe inflammation related to TB (n=31).
days (range 1-101 days).
ICU-related complications ( with 50% of the patients dying within the first 32 days and 75% of the patients dying within the first 75 days (Figure 1 ). The duration of the hospital stay was 87.1 days (range 3-340), the duration of ICU-care 21.6 days (range 3-119). Due to death, the duration of hospital stay was shorter in the non survivors group with 53.6 days (range 3-229 days) compared to survivors;
however, ICU-stay was longer with 31.2 days (range 3-119days) in patients who died compared to survivors.
Twenty-five of the survival patients failed to follow up after discharge and 9 (37.5%) of 24 evaluable patients died within 1 -124 months (median 13 months).
Factors found to be associated with in-hospital mortality in the univariate analysis (younger age, underweight, chronic pancreatitis, COPD, nosocomial infections, ARDS, development of renal failure, severe respiratory failure with need for mechanical ventilation) were included in the multivariate disciminant analysis, Table 3 shows the factors independently associated with in-hospital mortality.
Discussion
This retrospective analysis of 58 TB patients requiring intensive care found an in-hospital mortality rate of 25.9% which was associated with a number of independent risk factors factors such as, acute renal failure, ARDS, nosocomial infections and the need for mechanical ventilation.
Others studies reported mortality rates up to 90% in patients suffering from miliary tuberculosis and ARDS (10, 23) . Patients who died were significantly older than the survivors but the average age of all patients included was relatively low. The incidence of TB in Germany shows two peaks in age distribution, the first ranges between 40-50 years of age, while the second is above 70 years (24) . The first peak is commonly interpreted as a new acquired TB infection and the second as TB reactivation. Our findings with a mean age of 48 years in ICU-treated TB patients suggest that newly acquired TB infections may present a more severe cause of the disease. However, the average age of patients in other studies ranged between 41 years (9) and 59 years (2) . A further gender-related finding was that severe TB affected more often male patients, which is in agreement with other studies. In this respect, the proportion of female patient ranges from 13% (present study) to 45% (15) .
The vast majority of the present patients presented with severe radiographic alterations or miliary TB. According the NTRDA classification two third of our patients had extensive bilateral infiltrates and cavitary lesions. The outcome of these patients was worse than of patients with less radiographic alterations. Radiographic findings contributing to mortality were pneumonic pattern and consolidation. By contrast, cavitary, interstitial or nodular pattern were of similar percentage in survivors and nonsurvivors which is in agreement with earlier studies (5, 6, 9, 25) . Comorbidity is a further factor associated with mortality. In our study, a history of chronic pancreatitis was identified as an independent risk factor, which is most often related to chronic alcohol abuse. However, a history of alcohol abuse (37 patients) and/or liver function impairment (39 patients) did not influence mortality rates in the present study
We demonstrated that decompensation or development of renal failure as a complication during intensive care was highly influencing the outcome. Rao et al. (15) found that end stage renal failure requiring dialysis was a further comorbidity factor predicting mortality. Piqueras (10) described acute renal failure in 7/9 patients with no patients surviving. In the study of Penner et al. (5) 7/13 TB patients developed multiorgan failure and 6 of them died. However, other studies did not find a correlation between mortality and acute renal failure (2, 9, 26).
Treatment has been also been considered to be an important factor affecting patients´outcome (5, 27, 28) . We found that a higher mortality is present in patients who did not receive an optimal treatment with a triple combination including INH and RMP. Most often other causes than TB resistance led to the withdrawal of INH and RMP, with impaired liver function being a major reason, but other causes have been also described (29) . The MDR rate in our study reached 3.5%, which is slightly increased in comparison to the MDR rate of 1.4% reported in
Germany for the year 1999 (24).
Moreover, critically ill patients are more likely to develop organ dysfunction, which represents a further cause for changes in the treatment regimen.
Although the duration from first symptoms to treatment onset was earlier outlined as a crucial factor to mortality (30), our patients with longer history of symptoms such as fever or hemoptysis did not show a significantly worse outcome.
Since the emergence of AIDS, TB and HIV infection have been intimately connected. The presentation of TB is generally known to be related to the degree of immunosuppression and TB dissemination and extrapulmonary localisation are reported to be more frequent in patients with HIV infection (31) . Only 7% of our patients were infected with HIV but the HIV status did not influence the mortality. However, this percentage shows an considerable increase of the coinfection rate in our institution compared to a rate of 2% reported in 1995 (32) .
A further factor positively related to mortality was the development of a nosocomial infection during ICU-stay. Pneumonia and sepsis were most frequently found in our study. An early report suggests also a significant impact of nosocomial infections on the mortality of critically ill TB patients (33) .
In conclusion, the present study found a high mortality rate in TB patients requiring ICU-care.
Interestingly, some of the predictive factors for mortality, such as nosocomial infections, were actually related to the intensive care procedures. These findings suggest that a better preventive approach of these patients, which are prone to prolonged mechanical ventilation and frequent nosocomial infections, may improve the outcome. Figure 1 : In-hospital survival by Kaplan-Meier (n=58) 
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